The biological properties of iron oxide core high-density lipoprotein in experimental atherosclerosis

Biomaterials

Volumn 32, Issue 1, 2011, Pages 206-213

  Skajaa, Torjus ^a,b   Cormode, David P ^a   Jarzyna, Peter A ^a   Delshad, Amanda ^a   Blachford, Courtney ^c,e   Barazza, Alessandra ^c,e   Fisher, Edward A ^c   Gordon, Ronald E ^d   Fayad, Zahi A ^a   Mulder, Willem J M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI HOSPITAL   (United States)

^e One Gustave L Levy Place ^*  (United States)

Author keywords

High density lipoprotein; Iron oxide nanoparticles; Nanoparticle excretion; Optical imaging; Transmission electron microscopy

Indexed keywords

APOLIPOPROTEINS; BIOLOGICAL PROPERTIES; CHOLESTERYL ESTERS; HIGH-DENSITY LIPOPROTEINS; IN-VITRO; IN-VIVO; IRON OXIDE NANOPARTICLES; MULTI-MODAL APPROACH; NANOPARTICLE DYNAMICS; OPTICAL IMAGING; SUB-CELLULAR; TEM; TRANSMISSION ELECTRON;

BEHAVIORAL RESEARCH; BIOLOGICAL MATERIALS; BIOMATERIALS; ESTERS; LIGHT TRANSMISSION; MAGNETIC RESONANCE IMAGING; MONOLAYERS; NANOMAGNETICS; NANOPARTICLES; OPTICAL IMAGE STORAGE; PHOSPHOLIPIDS; RESONANCE; TRANSMISSION ELECTRON MICROSCOPY;

IRON OXIDES;

CHOLESTEROL; CHOLESTEROL ESTER; HIGH DENSITY LIPOPROTEIN; IRON OXIDE; LOW DENSITY LIPOPROTEIN; NANOPARTICLE; PLASMA PROTEIN; TRIACYLGLYCEROL; TRITIUM; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA WALL; ARTICLE; ATHEROSCLEROSIS; BILE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOTHELIUM CELL; FECES; HUMAN; HUMAN CELL; IMAGING SYSTEM; KNOCKOUT MOUSE; LIGHT SCATTERING; LIVER CELL; MACROPHAGE; MOUSE; NANOTECHNOLOGY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; WILD TYPE;

ANIMALS; AORTA; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIOLOGICAL TRANSPORT; CELL SURVIVAL; CHOLESTEROL; FERRIC COMPOUNDS; HEP G2 CELLS; HEPATOCYTES; HUMANS; INJECTIONS, INTRAVENOUS; KUPFFER CELLS; LIPOPROTEINS, HDL; MACROPHAGES; MICE; MICE, KNOCKOUT; MICROSCOPY, CONFOCAL; NANOPARTICLES;

EID: 78349308114     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.08.078     Document Type: Article

References (30)

1. Mahley R.W., Innerarity T.L., Rall S.C., Weisgraber K.H. Plasma-lipoproteins-apolipoprotein structure and function. J Lipid Res 1984, 25(12):1277-1294.
2. Feig J.E., Shamir R., Fisher E.A. Atheroprotective effects of HDL: beyond reverse cholesterol transport. Curr Drug Targ 2008, 9(3):196-203.
3. Barter P., Kastelein J., Nunn A., Hobbs R. High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions. Atherosclerosis 2003, 168(2):195-211.
4. Viles-Gonzalez J.F., Fuster V., Corti R., Badimon J.J. Emerging importance of HDL cholesterol in developing high-risk coronary plaques in acute coronary syndromes. Curr Opin Cardiol 2003, 18(4):286-294.
5. Li H.-h., Lyles D.S., Pan W., Alexander E., Thomas M.J., Sorci-Thomas M.G. ApoA-I structure on discs and spheres. Variable helix registry and conformational states. J Biol Chem 2002, 277(42):39093-39101.
6. Datta G., Chaddha M., Hama S., Navab M., Fogelman A.M., Garber D.W., et al. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide. J Lipid Res 2001, 42(7):1096-1104.
7. Silva R.A.G.D., Huang R., Morris J., Fang J., Gracheva E.O., Ren G., et al. Structure of apolipoprotein A-I in spherical high density lipoproteins of different sizes. Proc Nat Acad Sci 2008, 105(34):12176-12181.
8. Thomas M.J., Bhat S., Sorci-Thomas M.G. Three-dimensional models of HDL apoA-I: implications for its assembly and function. J Lipid Res 2008, 49(9):1875-1883.
9. Segrest J.P., Jones M.K., Klon A.E., Sheldahl C.J., Hellinger M., De Loof H., et al. A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein. J Biol Chem 1999, 274(45):31755-31758.
10. Lusis A.J. Atherosclerosis. Nature 2000, 407(6801):233-241.
11. Florentin M., Liberopoulos E.N., Wierzbicki A.S., Mikhailidis D.P. Multiple actions of high-density lipoprotein. Curr Opin Cardiol 2008, 23(4):370-378.
12. Naghavi M., Libby P., Falk E., Casscells S.W., Litovsky S., Rumberger J., et al. From vulnerable plaque to vulnerable patient-a call for new definitions and risk assessment strategies: part II. Circulation 2003, 108(15):1772-1778.
13. Tall A.R. Cholesterol efflux pathways and other potential mechanisms involved in the athero-protective effect of high density lipoproteins. J Int Med 2008, 263(3):256-273.
14. Acton S., Rigotti A., Landschulz K.T., Xu S.Z., Hobbs H.H., Krieger M. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science 1996, 271(5248):518-520.
15. Cormode D.P., Skajaa T., van Schooneveld M.M., Koole R., Jarzyna P., Lobatto M.E., et al. Nanocrystal core high-density lipoproteins: a multimodality contrast agent platform. Nano Lett 2008, 8(11):3715-3723.
16. Havel R.J., Eder H.A., Bragdon J.H. Distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 1955, 34(9):1345-1353.
17. Cormode D.P., Briley-Saebo K.C., Mulder W.J.M., Aguinaldo J.G.S., Barazza A., Ma Y., et al. An apoA-I mimetic peptide high-density-lipoprotein-based MRI contrast agent for atherosclerotic plaque composition detection. Small 2008, 4(9):1437-1444.
18. Rong J.X., Kusunoki J., Oelkers P., Sturley S.L., Fisher E.A. Acyl-coenzymeA (CoA):cholesterol acyltransferase inhibition in rat and human aortic smooth muscle cells is nontoxic and retards foam cell formation. Arterioscler Thromb Vasc Biol 2005, 25(1):122-127.
19. Forte T.M., Nordhausen R.W. Electron-microscopy of negatively stained lipoproteins. Meth Enzymol 1986, 128:442-457.
20. Horak D., Babic M., Jendelova P., Herynek V., Trchova M., Pientka Z., et al. D-Mannose-modified iron oxide nanoparticles for stem cell labeling. Bioconjug Chem 2007, 18(3):635-644.
21. Bruns O.T., Ittrich H., Peldschus K., Kaul M.G., Tromsdorf U.I., Lauterwasser J., et al. Real-time magnetic resonance imaging and quantification of lipoprotein metabolism in vivo using nanocrystals. Nat Nano 2009, 4(3):193-201.
22. Thaxton C.S., Daniel W.L., Giljohann D.A., Thomas A.D., Mirkin C.A. Templated spherical high density lipoprotein nanoparticles. J Am Chem Soc 2009, 131(4):1384-1385.
23. Rothblat G.H., de la Llera-Moya M., Atger V., Kellner-Weibel G., Williams D.L., Phillips M.C. Cell cholesterol efflux: integration of old and new observations provides new insights. J Lipid Res 1999, 40(5):781-796.
24. Remaley A.T., Thomas F., Stonik J.A., Demosky S.J., Bark S.E., Neufeld E.B., et al. Synthetic amphipathic helical peptides promote lipid efflux from cells by an ABCA1-dependent and an ABCA1-independent pathway. J Lipid Res 2003, 44(4):828-836.
25. Davidson W.S., Lund-Katz S., Johnson W.J., Anantharamaiah G.M., Palgunachari M.N., Segrest J.P., et al. The influence of apolipoprotein structure on the efflux of cellular free cholesterol to high density lipoprotein. J Biol Chem 1994, 269(37):22975-22982.
26. Jonas A. Interaction of bovine serum high density lipoprotein with mixed vesicles of phosphatidylcholine and cholesterol. J Lipid Res 1979, 20(7):817-824.
27. Breslow J.L. Mouse models of atherosclerosis. Science 1996, 272:685-688.
28. Zadelaar S., Kleemann R., Verschuren L., de Vries-Van der Weij J., van der Hoorn J., Princen H.M., et al. Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 2007, 27(8):1706-1721.
29. Sanhai W.R., Sakamoto J.H., Canady R., Ferrari M. Seven challenges for nanomedicine. Nat Nano 2008, 3(5):242-244.
30. Choi H.S., Liu W., Misra P., Tanaka E., Zimmer J.P., Ipe B.I., et al. Renal clearance of quantum dots. Nat Biotech 2007, 25:1165-1170.